American Medical Systems Holdings Inc. (AMMD) said that it raised its fourth-quarter adjusted earnings outlook to a range of $0.32 - $0.35 per share, from previous guidance of $0.29 - $0.33 per share.
The company reported preliminary sales of $146.0 million for the fourth quarter of 2009, a 9.0% increase over sales of $134.0 million in the comparable quarter of 2008. The company said that the weakening of the U.S. dollar compared to the fourth quarter of 2008 positively affected revenue comparisons for the quarter by $3.9 million. Adjusting for the positive impact of the weaker U.S. dollar results in fourth quarter growth of 6.1 percent over the same period last year.
Analysts polled by Thomson Reuters expect the company to report earnings of $0.33 per share on revenues of $140.18 million for the fourth-quarter. Analysts' estimates typically exclude special items.
For full year 2009, the company now expects adjusted earnings to the range of $1.12 - $1.15. per share, compared to prior range of $1.10 - $1.14 per share.
Preliminary sales for the year 2009 were reported at $519.3 million, a 3.5% increase over sales of $501.6 million for the year 2008. The strengthening of the U.S. dollar for the full year 2009 compared to 2008 negatively affected revenue comparisons between years by $8.2 million. Adjusting for the negative impact of foreign currency fluctuations results in 2009 revenue growth over 2008 of 5.2%.
Analysts polled by Thomson Reuters expect the company to report earnings of $1.14 per share on revenues of $513.47 million for fiscal 2009.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.